ReviewGenetics in medicine : official journal of the American College of Medical Genetics2016
Difficulties in diagnosing Marfan syndrome using current FBN1 databases.
Review in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06257004 (Genome-wide Epistasis for Cardiovascular Severity in Marfan Study), which is not on this map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Genome-wide Epistasis for Cardiovascular Severity in Marfan Study
Who cites it
9 citing papers in PubMed.
- Re-evaluation of a Fibrillin-1 Gene Variant of Uncertain Significance Using the ClinGen Guidelines.Annals of laboratory medicine · 2024Article
- Article
- The Molecular Genetics of Marfan Syndrome.International journal of medical sciences · 2021Review
- Genomic Screening: The Mutation and the Mustard Seed.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2018Article
- Identification of Novel Clinically Relevant Variants in 70 Southern Chinese patients with Thoracic Aortic Aneurysm and Dissection by Next-generation Sequencing.Scientific reports · 2017Article
- A novel molecular diagnostics platform for somatic and germline precision oncology.Molecular genetics & genomic medicine · 2017Article
- Evaluating the quality of Marfan genotype-phenotype correlations in existing FBN1 databases.Genetics in medicine : official journal of the American College of Medical Genetics · 2017Article
- Aortic events in a nationwide Marfan syndrome cohort.Clinical research in cardiology : official journal of the German Cardiac Society · 2017Article
- Prevalence, incidence, and age at diagnosis in Marfan Syndrome.Orphanet journal of rare diseases · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe diagnostic criteria of Marfan syndrome (MFS) highlight the importance of a FBN1 mutation test in diagnosing MFS. As genetic sequencing becomes better, cheaper, and more accessible, the expected increase in the number of genetic tests will become evident, resulting in numerous genetic variants that need to be evaluated for disease-causing effects based on database information. The aim of this study was to evaluate genetic variants in four databases and review the relevant literature.
methodsWe assessed background data on 23 common variants registered in ESP6500 and classified as causing MFS in the Human Gene Mutation Database (HGMD). We evaluated data in four variant databases (HGMD, UMD-FBN1, ClinVar, and UniProt) according to the diagnostic criteria for MFS and compared the results with the classification of each variant in the four databases.
resultsNone of the 23 variants was clearly associated with MFS, even though all classifications in the databases stated otherwise.
conclusionA genetic diagnosis of MFS cannot reliably be based on current variant databases because they contain incorrectly interpreted conclusions on variants. Variants must be evaluated by time-consuming review of the background material in the databases and by combining these data with expert knowledge on MFS. This is a major problem because we expect even more genetic test results in the near future as a result of the reduced cost and process time for next-generation sequencing.Genet Med 18 1, 98-102.
Indexed as
Identifiers
25812041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.